PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE +/- TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER. [Trattamento preoperatorio con letrozolo ± Triptorelin nel carcinoma mammario localmente avanzato endocrinoresponsivo ER e PgR greater than 50 %]

Trial Profile

PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE +/- TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER. [Trattamento preoperatorio con letrozolo ± Triptorelin nel carcinoma mammario localmente avanzato endocrinoresponsivo ER e PgR greater than 50 %]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Dec 2012

At a glance

  • Drugs Letrozole (Primary) ; Triptorelin
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top